Previous study reported that, in lung cancer, increased Gankyrin expression was required for the constitutive activation of Akt and tumorigenesis in those who have ras mutation [33], which indicated that Gankyrin might affect the prognosis of NSCLC partially by promoting tumor growth through activating Akt signal. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.